Passive smoking induces atherogenic changes in low-density lipoprotein

被引:106
|
作者
Valkonen, M [1 ]
Kuusi, T [1 ]
机构
[1] Univ Helsinki, Dept Med, FIN-00014 Helsinki, Finland
关键词
lipoproteins; coronary disease; smoking; atherosclerosis;
D O I
10.1161/01.CIR.97.20.2012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-According to the American Heart Association, passive smoking is an important risk factor for coronary heart disease (CHD), but the mechanisms underlying this association are not fully understood. We studied the acute effect of passive smoking on the factors that influence the development of CHD: the antioxidant defense of human serum, the extent of lipid peroxidation, and the accumulation of LDL cholesterol in cultured human macrophages, the precursors of foam cells in atherosclerotic lesions. Methods and Results-Blood samples were collected during 2 ordinary working days from healthy, nonsmoking subjects (n=10) before and after (up to 5.5 hours) spending half an hour in a smoke-free area (day 1) or in a room for smokers (day 2). Passive smoking caused an acute decrease (1.5 hours after exposure) in serum ascorbic acid (P<.001) and in serum antioxidant defense (P<.001), a decreased capacity of LDL to resist oxidation (P<.01), and the appearance of increased amounts of lipid peroxidation end products in serum (P<.01). Finally, LDL isolated from subjects after passive smoking was taken up by cultured macrophages at an increased rate (P<.05). Conclusions-Exposure of nonsmoking subjects to secondhand smoke breaks down the serum antioxidant defense, leading to accelerated lipid peroxidation, LDL modification, and accumulation of LDL cholesterol in human macrophages. These data provide the pathophysiological background for the recent epidemiological evidence about the increased CHD risk among passive smokers.
引用
收藏
页码:2012 / 2016
页数:5
相关论文
共 50 条
  • [1] STRUCTURE OF ATHEROGENIC LOW-DENSITY LIPOPROTEIN (LDL)
    TALL, A
    RUDEL, L
    SMALL, D
    ATKINSON, D
    [J]. CIRCULATION, 1978, 58 (04) : 170 - 170
  • [2] Oxidized Low-Density Lipoprotein and its Atherogenic Potential
    Rangareddy, Harish
    Nagaraj, Shashidhar Kurpad
    Narayanaswamy, Soumya
    [J]. INTERNATIONAL JOURNAL OF BIOMEDICINE, 2022, 12 (03) : 339 - 343
  • [3] Atherogenic changes of low-density lipoprotein susceptibility to oxidation, and antioxidant enzymes in pulmonary tuberculosis
    Nezami, Nariman
    Ghorbanihaghjo, Amir
    Rashtchizadeh, Nadereh
    Argani, Hassan
    Tafrishinejad, Arash
    Ghorashi, Sona
    Hajhosseini, Babak
    [J]. ATHEROSCLEROSIS, 2011, 217 (01) : 268 - 273
  • [4] SMOKING INFLUENCES THE ATHEROGENIC POTENTIAL OF LOW-DENSITY-LIPOPROTEIN
    SCHEFFLER, E
    WIEST, E
    WOEHRLE, J
    OTTO, I
    SCHULZ, I
    HUBER, L
    ZIEGLER, R
    DRESEL, HA
    [J]. CLINICAL INVESTIGATOR, 1992, 70 (3-4): : 263 - 268
  • [5] Association of atherogenic low-density lipoprotein subfractions with carotid atherosclerosis
    Landray, MJ
    Sagar, GS
    Muskin, J
    Murray, S
    Holder, RL
    Lip, GYH
    [J]. QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS, 1998, 91 (05): : 345 - 351
  • [6] PERTURBATION OF ENDOTHELIAL PINOCYTOSIS BY ATHEROGENIC LEVELS OF LOW-DENSITY LIPOPROTEIN
    HOLLAND, JA
    PRITCHARD, KA
    ROGERS, NJ
    STEMERMAN, MB
    [J]. ARTERIOSCLEROSIS, 1988, 8 (05): : A616 - A616
  • [7] Triglyceride, small, dense low-density lipoprotein, and the atherogenic lipoprotein phenotype.
    Austin M.A.
    [J]. Current Atherosclerosis Reports, 2000, 2 (3) : 200 - 207
  • [8] The effects of weight gain after smoking cessation on atherogenic α1-antitrypsin–low-density lipoprotein
    Maki Komiyama
    Hiromichi Wada
    Shuichi Ura
    Hajime Yamakage
    Noriko Satoh-Asahara
    Sayaka Shimada
    Masaharu Akao
    Hiroshi Koyama
    Koichi Kono
    Akira Shimatsu
    Yuko Takahashi
    Koji Hasegawa
    [J]. Heart and Vessels, 2015, 30 : 734 - 739
  • [9] Evaluation and management of atherogenic dyslipidemia:: beyond low-density lipoprotein cholesterol
    Després, JP
    Lemieux, I
    Dagenais, GR
    Cantin, B
    Lamarche, B
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2001, 165 (10) : 1331 - 1333
  • [10] Fluvastatin lowers atherogenic dense low-density lipoproteins in postmenopausal women with the atherogenic lipoprotein phenotype
    März, W
    Scharnagl, H
    Abletshauser, C
    Hoffmann, MM
    Berg, A
    Keul, J
    Wieland, H
    Baumstark, MW
    [J]. CIRCULATION, 2001, 103 (15) : 1942 - 1948